Candidiasis

Infectious Diseases of the Fetus and Newborn Infant

Volumn , Issue , 2006, Pages 1107-1128

  Bendel, Catherine M ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 34548436780     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B0-72-160537-0/50035-9     Document Type: Chapter

References (262)

1. Pfaller MA Nosocomial candidiasis: emerging species, reservoirs, and modes of transmission. Clin Infect Dis 1996, 22:S89-S94.
2. Butler KM, Baker CJ Candida: an increasingly important pathogen in the nursery. Pediatr Clin North Am 1988, 35:543-563.
3. Rangel-Frausto MS, Wiblin T, Blumberg HM, et al. National Epidemiology of Mycoses Survey (NEMIS): variations in rates of bloodstream infections due to Candida species in seven surgical intensive care units and six neonatal intensive care units. Clin Infect Dis 1999, 29:253-258.
4. Bendel CM, Hostetter MK Systemic candidiasis and other fungal infections in the newborn. Semin Pediatr Infect Dis 1994, 5:35-41.
5. Stoll BJ, Hansen N Infections in VLBW infants: studies from the NICHD Neonatal Research Network. Semin Perinatol 2003, 27:293-301.
6. Kossoff EH, Buescher ES, Karlowicz MG Candidemia in a neonatal intensive care unit: trends during fifteen years and clinical features of 111 cases. Pediatr Infect Dis J 1998, 17:504-508.
7. Saiman L, Ludington E, Pfaller M, et al. Risk factors for candidemia in neonatal intensive care unit patients. The National Epidemiology of Mycosis Survey study group. Pediatr Infect Dis J 2000, 19:319-324.
8. Faix RG Invasive neonatal candidiasis: comparison of albicans and parapsilosis infection. Pediatr Infect Dis J 1992, 11:88-93.
9. Pfaller MA, Diekema DJ, Jones RN, et al. Trends in antifungal susceptibility of Candida spp. isolated from pediatric and adult patients with bloodstream infections: SENTRY Antimicrobial Surveillance Program, 1997 to 2000. J Clin Microbiol 2002, 40:852-856.
10. Lemons JA, Bauer CR, Oh W, et al. Very low birth weight outcomes of the National Institute of Child Health and Human Development Neonatal Research Network, January 1995 through December 1996. NICHD Neonatal Research Network. Pediatrics 2001, 107:E1.
11. Cole GT, Halawa AA, Anaissie EJ The role of the gastrointestinal tract in hematogenous candidiasis: from the laboratory to the bedside. Clin Infect Dis 1996, 22:S73-S88.
12. Eubanks PJ, de Virgilio C, Klein S, et al. Candida sepsis in surgical patients. Am J Surg 1993, 166:617-619.
13. Emori TG, Gaynes RP An overview of nosocomial infections, including the role of the microbiology laboratory. Clin Microbiol Rev 1993, 6:428-442.
14. Richards MJ, Edwards JR, Culver DH, et al. Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System. Crit Care Med 1999, 27:887-892.
15. Polin RA The "ins and outs" of neonatal sepsis. J Pediatr 2003, 143:3-4.
16. Stoll BJ, Hansen N, Fanaroff AA, et al. Changes in pathogens causing early-onset sepsis in very-low-birth-weight infants. N Engl J Med 2002, 347:240-247.
17. Chapman RL, Faix RG Invasive neonatal candidiasis: an overview. Semin Perinatol 2003, 27:352-356.
18. Bendel CM, St.Sauver J, Carlson S, et al. Epithelial adhesion in yeast species: correlation with surface expression of the integrin analog. J Infect Dis 1995, 171:1660-1663.
19. Pfaller MA, Jones RN, Doern GV, et al. Bloodstream infections due to Candida species: SENTRY antimicrobial surveillance program in North America and Latin America, 1997-1998. Antimicrob Agents Chemother 2000, 44:747-751.
20. Pfaller MA, Jones RN, Doern GV, et al. International surveillance of blood stream infections due to Candida species in the European SENTRY program: species distribution and antifungal susceptibility including the investigational triazole and echinocandin agents. SENTRY Participant Group (Europe). Diagn Microbiol Infect Dis 1999, 35:19-25.
21. Trick WE, Fridkin SK, Edwards JR, et al. Secular trend of hospital-acquired candidemia among intensive care unit patients in the United States during 1989-1999. Clin Infect Dis 2002, 35:627-630.
22. Fairchild KD, Tomkoria S, Sharp EC, et al. Neonatal Candida glabrata sepsis: clinical and laboratory features compared with other Candida species. Pediatr Infect Dis J 2002, 21:39-43.
23. El-Mohandes AE, Johnson-Robbins L, Keiser JF, et al. Incidence of Candida parapsilosis colonization in an intensive care nursery population and its association with invasive fungal disease. Pediatr Infect Dis J 1994, 13:520-524.
24. Benjamin DK, Ross K, McKinney RE, et al. When to suspect fungal infection in neonates: a clinical comparison of Candida albicans and Candida parapsilosis fungemia with coagulase-negative staphylococcal bacteremia. Pediatrics 2000, 106:712-718.
25. Rowen JL, Rench MA, Kozinetz CA, et al. Endotracheal colonization with Candida enhances risk of systemic candidiasis in very low birth weight neonates. J Pediatr 1994, 124:789-794.
26. Baley JE, Kliegman RM, Boxerbaum B, et al. Fungal colonization in the very low birth weight infant. Pediatrics 1986, 78:225-232.
27. Pfaller M, Wenzel R Impact of the changing epidemiology of fungal infections in the 1990s. Eur J Clin Microbiol Infect Dis 1992, 11:287-291.
28. Huang YC, Lin TY, Peng HL, et al. Outbreak of Candida albicans fungaemia in a neonatal intensive care unit. Scand J Infect Dis 1998, 30:137-142.
29. Kaufman D, Boyle R, Hazen KC, et al. Fluconazole prophylaxis against fungal colonization and infection in preterm infants. N Engl J Med 2001, 345:1660-1666.
30. Waggoner-Fountain LA, Walker MW, Hollis RJ, et al. Vertical and horizontal transmission of unique Candida species to premature newborns. Clin Infect Dis 1996, 22:803-808.
31. Kozinn PJ, Taschdjian CL, Weiner H Incidence and pathogenesis of neonatal candidiasis. Pediatrics 1958, 21:421-429.
32. Bendel CM Colonization and epithelial adhesion in the pathogenesis of neonatal candidiasis. Semin Perinatol 2003, 27:357-364.
33. Rowen JL, Tate JM, Nordoff N, et al. Candida isolates from neonates: frequency of misidentification and reduced fluconazole susceptibility. J Clin Microbiol 1999, 37:3735-3737.
34. Carlson S, Hostetter M, Finkel D, et al. Genotypic and functional analysis of Candida albicans strains from mother-infant pairs. Pediatr Res 1994, 35:295A.
35. Johnson DE, Thompson TR, Ferrieri P Congenital candidiasis. Am J Dis Child 1981, 135:273-275.
36. Dvorak AM, Gavaller B Congenital systemic candidiasis. Report of a case. N Engl J Med 1966, 274:540-543.
37. Gonzalez Ochoa A, Dominguez L Various epidemiological and pathogenic findings on oral moniliasis in newborn infants. Rev Inst Salubr Enferm Trop 1957, 17:1-12.
38. Baley JE Neonatal candidiasis: the current challenge. Clin Perinatol 1991, 18:263-280.
39. Warnock DW Typing of Candida albicans. J Hosp Infect 1984, 5:244-252.
40. Fidel PL, Vazquez JA, Sobel JD Candida glabrata: review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans. Clin Microbiol Rev 1999, 12:80-96.
41. Hedderwick SA, Lyons MJ, Liu M, et al. Epidemiology of yeast colonization in the intensive care unit. Eur J Clin Microbiol Infect Dis 2000, 19:663-670.
42. Sherertz RJ, Gledhill KS, Hampton KD, et al. Outbreak of Candida bloodstream infections associated with retrograde medication administration in a neonatal intensive care unit. J Pediatr 1992, 120:455-461.
43. Fox BC, Mobley HL, Wade JC The use of a DNA probe for epidemiological studies of candidiasis in immunocompromised hosts. J Infect Dis 1989, 159:488-494.
44. White MH Epidemiology of invasive candidiasis: recent progress and current controversies. Int J Infect Dis 1997, 1:S7-S10.
45. Reef SE, Lasker BA, Butcher DS, et al. Nonperinatal nosocomial transmission of Candida albicans in a neonatal intensive care unit: prospective study. J Clin Microbiol 1998, 36:1255-1259.
46. Boyce JM, Pittet D Guideline for hand hygiene in health-care settings: recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. Infect Control Hosp Epidemiol 2002, 23:S3-S40.
47. Vaudry WL, Tierney AJ, Wenman WM Investigation of a cluster of systemic Candida albicans infections in a neonatal intensive care unit. J Infect Dis 1988, 158:1375-1379.
48. Solomon SL, Alexander H, Eley JW, et al. Nosocomial fungemia in neonates associated with intravascular pressure-monitoring devices. Pediatr Infect Dis J 1986, 5:680-685.
49. Yagupsky P Interpretation of blood culture results. Infect Control Hosp Epidemiol 1992, 13:693.
50. St-Germain G, Laverdiere M Torulopsis candida, a new opportunistic pathogen. J Clin Microbiol 1986, 24:884-885.
51. Sullivan D, Coleman D Candida dubliniensis: characteristics and identification. J Clin Microbiol 1998, 36:329-334.
52. Calderone RA Taxonomy and biology of Candida. Candida and Candidiasis 2002, 15-28. ASM Press, Washington. R.A. Calderone (Ed.).
53. Moran GP, Sullivan DJ, Coleman DC Emergence of non- Candida albicans Candida species as pathogens. Candida and Candidiasis 2002, 37-54. ASM Press, Washington, DC. R.A. Calderone (Ed.).
54. Schauer F, Hanschke R Taxonomy and ecology of the genus Candida. Mycoses 1999, 42:12-21.
55. San-Blas G, Travassos LR, Fries BC, et al. Fungal morphogenesis and virulence. Med Mycol 2000, 38:79-86.
56. Bendel CM, Kinneberg KM, Jechorek RP, et al. Systemic infection following intravenous inoculation of mice with Candida albicans int1 mutant strains. Mol Genet Metab 1999, 67:343-351.
57. Bendel CM, Wiesner SM, Garni RM, et al. Cecal colonization and systemic spread of Candida albicans in mice treated with antibiotics and dexamethasone. Pediatr Res 2002, 51:290-295.
58. Bendel CM, Hess DJ, Garni RM, et al. Comparative virulence of Candida albicans yeast and filamentous forms in orally and intravenously inoculated mice. Crit Care Med 2003, 31:501-507.
59. Odds FC Candida species and virulence. ASM News 1994, 60:313-318.
60. Calderone RA, Fonzi WA Virulence factors of Candida albicans. Trends Microbiol 2001, 9:327-335.
61. Gale CA, Bendel CM, McClellan M, et al. Linkage of adhesion, filamentous growth, and virulence in Candida albicans to a single gene, INT1. Science 1998, 279:1355-1358.
62. Braun B, Johnson AD Control of filament formation in Candida albicans by the transcriptional repressor TUP1. Science 1997, 277:105-109.
63. Lo HJ, Kohler JR, DiDominico B Non-filamentous C. albicans mutants are avirulent. Cell 1997, 90:939-949.
64. Stabb JF, Sundstrom P Genetic organization and sequence analysis of the hyphae-specific cell wall protein gene HWP1 of Candida albicans. Yeast 1998, 14:682-686.
65. Hoyer LL The ALS gene family of Candida albicans. Trends Microbiol 2001, 9:176-180.
66. Critchley IA, Douglas LJ Differential adhesion of pathogenic Candida species to epithelial and inert surfaces. FEMS Microbiol Lett 1985, 28:199-203.
67. Cutler JE Putative virulence factors of Candida albicans. Ann Rev Microbiol 1991, 45:187-218.
68. Calderone RA, Linehan L, Wadsworth E Identification of C3d receptors on Candida albicans. Infect Immun 1998, 56:252-258.
69. Fukazawa T, Kagaya K Molecular basis of adhesion of Candida albicans. J Med Vet Mycol 1997, 35:87-89.
70. Gustafson KS, Vercellotti GM, Bendel CM, et al. Molecular mimicry in Candida albicans: role of an integrin analogue in adhesion of the yeast to human endothelium. J Clin Invest 1991, 87:1896-1902.
71. Wiesner SM, Bendel CM, Hess DJ, et al. Adherence of yeast and filamentous forms of Candida albicans to cultured enterocytes. Crit Care Med 2002, 30:677-683.
72. Hostetter MK New insights into candidal infections. Adv Pediatr 1996, 43:209-230.
73. Hostetter MK Adhesins and ligands involved in the interaction of Candida spp. with epithelial and endothelial surfaces. Clin Microbiol Rev 1994, 7:29-42.
74. Hawser SP, Douglas LJ Biofilm formation by Candida species on the surface of catheter materials in vitro. Infect Immun 1994, 62:915-921.
75. Hawser SP, Baillie GS, Douglas LJ Production of extracellular matrix by Candida albicans biofilms. J Med Microbiol 1998, 47:253-256.
76. Baillie GS, Douglas LJ Candida biofilms and their susceptibility to antifungal agents. Methods Enzymol 1999, 310:644-656.
77. Baillie GS, Douglas LJ Role of dimorphism in the development of Candida albicans biofilms. J Med Microbiol 1999, 48:671-679.
78. Faix RG, Kovarik SM Polymicrobial sepsis among intensive care nursery infants. J Perinatol 1989, 9:131-136.
79. Klotz SA, Smith RL A fibronectin receptor on Candida albicans mediates adherence of the fungus to extracellular matrix. J Infect Dis 1991, 163:604-610.
80. Bendel CM, Hostetter MK Distinct mechanisms of epithelial adhesion for Candida albicans and Candida tropicalis: identification of the participating ligands and development of inhibitory peptides. J Clin Invest 1993, 92:1840-1849.
81. Brieland J, Essig D, Jackson C, et al. Comparison of pathogenesis and host immune responses to Candida glabrata and Candida albicans in systemically infected immunocompetent mice. Infect Immun 2001, 69:5046-5055.
82. Pappu-Katikaneni LD, Rao KP, Banister E Gastrointestinal colonization with yeast species and Candida septicemia in very low birth weight infants. Mycoses 1990, 33:20-23.
83. Thong YH, Ferrante A Alternative pathway of complement activation by Candida albicans. Aust N Z J Med 1978, 8:620-622.
84. Warnock DW, Milne JD, Fielding AM Immunoglobulin classes of human serum antibodies in vaginal candidiasis. Mycopathologia 1978, 63:173-175.
85. Gordon DL, Johnson GM, Hostetter MK Characteristics of iC3b binding to human polymorphonuclear leucocytes. Immunology 1987, 60:553-558.
86. Stanley VC, Hurley R, Carroll CJ Distribution and significance of Candida precipitins in sera from pregnant women. J Med Microbiol 1972, 5:313-320.
87. Kirkpatrick CH Inhibition of growth of Candida albicans by iron-saturated lactoferrin: relation to host defense mechanisms in chronic mucocutaneous candidiasis. J Infect Dis 1971, 124:539-545.
88. Diamond RD, Krzesicki R, Wellinton J Damage to pseudohyphal forms of Candida albicans by neutrophils in the absence of serum in vitro. J Clin Invest 1978, 61:349-356.
89. Botas CM, Kurlat I, Young SM, et al. Disseminated candidal infections and intravenous hydrocortisone in preterm infants. Pediatrics 1995, 95:883-887.
90. Finer NN, Craft A, Vaucher YE, et al. Postnatal steroids: short-term gain, long-term pain?. J Pediatr 2000, 137:9-13.
91. Stark AR, Carlo WA, Tyson JE, et al. Adverse effects of early dexamethasone in extremely-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network. N Engl J Med 2001, 344:95-101.
92. Malloy PJ, Zhao X, Madani ND, et al. Cloning and expression of the gene from Candida albicans that encodes a high-affinity corticosteroid-binding protein. Proc Natl Acad Sci U S A 1993, 90:1902-1906.
93. Rotrosen D, Calderone RA, Edwards JE Adherence of Candida species to host tissues and plastic surfaces. Rev Infect Dis 1986, 8:73-85.
94. Johnson DE, Bass JL, Thompson TR, et al. Candida septicemia and right atrial mass secondary to umbilical vein catheterization. Am J Dis Child 1981, 135:275-277.
95. Eppes SC, Troutman JL, Gutman LT Outcome of treatment of candidemia in children whose central catheters were removed or retained. Pediatr Infect Dis J 1989, 8:99-104.
96. Faix RG Nonsurgical treatment of Candida endocarditis. J Pediatr 1992, 120:665-666.
97. Hostetter MK Handicaps to host defense. Effects of hyperglycemia on C3 and Candida albicans. Diabetes 1990, 39:271-275.
98. Stoll BJ, Gordon T, Korones SB, et al. Late-onset sepsis in very low birth weight neonates: a report from the National Institute of Child Health and Human Development Neonatal Research Network. J Pediatr 1996, 129:63-71.
99. Adderson EE, Pappin A, Pavia AT Spontaneous intestinal perforation in premature infants: a distinct clinical entity associated with systemic candidiasis. J Pediatr Surg 1998, 33:1463-1467.
100. Rowen JL Mucocutaneous candidiasis. Semin Perinatol 2003, 27:406-413.
101. Weese-Mayer DE, Fondriest DW, Brouillette RT, et al. Risk factors associated with candidemia in the neonatal intensive care unit: a case-control study. Pediatr Infect Dis J 1987, 6:190-196.
102. Evans EG, Rutter N Development of the epidermis in the newborn. Biol Neonate 1986, 49:74-80.
103. Ballow M, Cates KL, Rowe JC, et al. Development of the immune system in very low birth weight (less than 1500g) premature infants: concentrations of plasma immunoglobulins and patterns of infections. Pediatr Res 1986, 20:899-904.
104. Gordon DL, Hostetter MK Complement and host defense against microorganisms. Pathology 1986, 18:365-375.
105. Zach TL, Hostetter MK Biochemical abnormalities of the third component of complement in neonates. Pediatr Res 1989, 26:116-120.
106. al-Mulla ZS, Christensen RD Neutropenia in the neonate. Clin Perinatol 1995, 22:711-739.
107. Kennedy MJ, Volz PA Effect of various antibiotics on gastrointestinal colonization and dissemination by Candida albicans. Sabouraudia 1985, 23:265-273.
108. Lee BE, Cheung PY, Robinson JL, et al. Comparative study of mortality and morbidity in premature infants (birth weight, < 1,250g) with candidemia or candidal meningitis. Clin Infect Dis 1998, 27:559-565.
109. Stoll BJ, Hansen N, Fanaroff AA, et al. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics 2002, 110:285-291.
110. Diekema DJ, Messer SA, Brueggemann AB, et al. Epidemiology of candidemia: 3-year results from the emerging infections and the epidemiology of Iowa organisms study. J Clin Microbiol 2002, 40:1298-1302.
111. Fanaroff AA, Hack M, Walsh MC The NICHD neonatal research network: changes in practice and outcomes during the first 15 years. Semin Perinatol 2003, 27:281-287.
112. Helbock HJ, Insoft RM, Conte FA Glucocorticoid-responsive hypotension in extremely low birth weight newborns. Pediatrics 1993, 92:715-717.
113. Hoppe JE Treatment of oropharyngeal candidiasis and candidal diaper dermatitis in neonates and infants: review and reappraisal. Pediatr Infect Dis J 1997, 16:885-894.
114. Rowen JL, Atkins JT, Levy ML, et al. Invasive fungal dermatitis in the < or = 1000-gram neonate. Pediatrics 1995, 95:682-687.
115. Benjamin DKJ, Garges H, Steinbach WJ Candida bloodstream infections in neonates. Semin Perinatol 2003, 27:375-383.
116. Faix R, Chapman RL Central nervous system candidiasis in the high-risk neonate. Semin Perinatol 2003, 27:384-392.
117. Chapman RL, Faix RG Persistently positive cultures and outcome in invasive neonatal candidiasis. Pediatr Infect Dis J 2000, 19:822-827.
118. Benjamin DK, Poole C, Steinbach WJ, et al. Neonatal candidemia and end-organ damage: a critical appraisal of the literature using meta-analytic techniques. Pediatrics 2003, 112:634-640.
119. Baley JE, Ellis F Neonatal candidiasis: ophthalmologic infection. Semin Perinatol 2003, 27:401-405.
120. Drohan L, Colby CE, Brindle ME, et al. Candida (amphotericin-sensitive) lens abscess associated with decreasing arterial blood flow in a very low birth weight preterm infant. Pediatrics 2002, 110:e65.
121. Doctor BA, Newman N, Minich NM, et al. Clinical outcomes of neonatal meningitis in very-low birth-weight infants. Clin Pediatr (Phila) 2001, 40:473-480.
122. Marcinkowski M, Bauer K, Stoltenburg-Didinger G, et al. Fungal brain abscesses in neonates: sonographic appearances and corresponding histopathologic findings. J Clin Ultrasound 2001, 29:417-421.
123. Johnson DE, Conroy MM, Foker JE, et al. Candida peritonitis in the newborn. J Pediatr 1980, 97:298-300.
124. Benjamin DK, Fisher RG, McKinney RE, et al. Candidal mycetoma in the neonatal kidney. Pediatrics 1999, 104:1126-1129.
125. Winters WD, Shaw DW, Weinberger E Candida fungus balls presenting as intraventricular masses in cranial sonography. J Clin Ultrasound 1995, 23:266-270.
126. Bryant K, Maxfield C, Rabalais G Renal candidiasis in neonates with candiduria. Pediatr Infect Dis J 1999, 18:959-963.
127. Whyte RK, Hussain Z, deSa DJ Antenatal infections with Candida species. Arch Dis Child 1982, 57:528-535.
128. Hood IC, Browning D, deSa DJ, et al. Fetal inflammatory response in second trimester candidal chorioamnionitis. Early Hum Dev 1985, 11:1-10.
129. Rudolph N, Tariq AA, Reale MR, et al. Congenital cutaneous candidiasis. Arch Dermatol 1977, 113:1101-1103.
130. Schwartz DA, Reef S Candida albicans placentitis and funisitis: early diagnosis of congenital candidemia by histopathologic examination of umbilical cord vessels. Pediatr Infect Dis J 1990, 9:661-665.
131. Faix RG, Kovarik SM, Shaw TR, et al. Mucocutaneous and invasive candidiasis among very low birth weight (less than 1,500 grams) infants in intensive care nurseries: a prospective study. Pediatrics 1989, 83:101-107.
132. Gupta P, Faridi MM, Rawat S, et al. Clinical profile and risk factors for oral candidosis in sick newborns. Indian Pediatr 1996, 33:299-303.
133. Daftary SS, Desai SV, Shah MV, et al. Oral thrush in the new-born. Indian Pediatr 1980, 17:287-288.
134. Goins RA, Ascher D, Waecker N, et al. Comparison of fluconazole and nystatin oral suspensions for treatment of oral candidiasis in infants. Pediatr Infect Dis J 2002, 21:1165-1167.
135. Kleinegger CL, Lockhart SR, Vargas K, et al. Frequency, intensity, species, and strains of oral Candida vary as a function of host age. J Clin Microbiol 1996, 34:2246-2254.
136. Leyden JJ Diaper dermatitis. Dermatol Clin 1986, 4:23-28.
137. Leyden JJ, Kligman AM The role of microorganisms in diaper dermatitis. Arch Dermatol 1978, 114:56-59.
138. Roque H, Abdelhak Y, Young BK Intra-amniotic candidiasis. Case report and meta-analysis of 54 cases. J Perinat Med 1999, 27:253-262.
139. Darmstadt GL, Dinulos JG, Miller Z Congenital cutaneous candidiasis: clinical presentation, pathogenesis, and management guidelines. Pediatrics 2000, 105:438-444.
140. Pradeepkumar VK, Rajadurai VS, Tan KW Congenital candidiasis: varied presentations. J Perinatol 1998, 18:311-316.
141. Jin Y, Endo A, Shimada M, et al. Congenital systemic candidiasis. Pediatr Infect Dis J 1995, 14:818-820.
142. Baley JE, Silverman RA Systemic candidiasis: cutaneous manifestations in low birth weight infants. Pediatrics 1988, 82:211-215.
143. Barone SR, Krilov LR Neonatal candidal meningitis in a full-term infant with congenital cutaneous candidiasis. Clin Pediatr (Phila) 1995, 34:217-219.
144. Melville C, Kempley S, Graham J, et al. Early onset systemic Candida infection in extremely preterm neonates. Eur J Pediatr 1996, 155:904-906.
145. Fernandez M, Noyola DE, Rossmann SN, et al. Cutaneous phaecomycosis caused by Curvularia lunata and a review of Curvularia infections in pediatrics. Pediatr Infect Dis J 1999, 18:727-731.
146. Bryan MG, Elston DM, Hivnor C, et al. Phaeohyphimycosis in a premature infant. Cutis 2000, 65:137-140.
147. Leibovitz E, Iuster-Reicher A, Amitai M, et al. Systemic candidal infections associated with use of peripheral venous catheters in neonates: a 9-year experience. Clin Infect Dis 1992, 14:485-491.
148. Hensey OJ, Hart CA, Cooke RW Candida albicans skin abscesses. Arch Dis Child 1984, 59:479-480.
149. Bodey GP, Luna M Skin lesions associated with disseminated candidiasis. JAMA 1974, 229:1466-1468.
150. Dyke MP, Ott K Severe thrombocytopenia in extremely low birth weight infants with systemic candidiasis. J Paediatr Child Health 1993, 29:298-301.
151. Foker JE, Bass JL, Thompson T, et al. Management of intracardiac fungal masses in premature infants. J Thorac Cardiovasc Surg 1984, 87:244-250.
152. Richards MJ, Edwards JR, Culver DH, et al. Nosocomial infections in pediatric intensive care units in the United States. National Nosocomial Infections Surveillance System. Pediatrics 1999, 103:e39.
153. Gubbins PO, McConnell SA, Penzak SR Current management of funguria. Am J Health Syst Pharm 1999, 56:1929-1935.
154. Hitchcock RJ, Pallett A, Hall MA, et al. Urinary tract candidiasis in neonates and infants. Br J Urol 1995, 76:252-256.
155. Ruderman JW A clue (tip-off) to urinary infection with Candida. Pediatr Infect Dis J 1990, 9:586-588.
156. Faix RG Systemic Candida infections in infants in intensive care nurseries: high incidence of central nervous system involvement. J Pediatr 1984, 105:616-622.
157. Makhoul IR, Kassis I, Smolkin T, et al. Review of 49 neonates with acquired fungal sepsis: further characterization. Pediatrics 2001, 107:61-66.
158. Noyola DE, Fernandez M, Moylett EH, et al. Ophthalmologic, visceral, and cardiac involvement in neonates with candidemia. Clin Infect Dis 2001, 32:1018-1023.
159. Baley JE, Kliegman RM, Fanaroff AA Disseminated fungal infections in very low-birth-weight infants: clinical manifestations and epidemiology. Pediatrics 1984, 73:144-152.
160. Phillips JR, Karlowicz MG Prevalence of Candida species in hospital-acquired urinary tract infections in a neonatal intensive care unit. Pediatr Infect Dis J 1997, 16:190-194.
161. Karlowicz MG Candidal renal and urinary tract infections in neonates. Semin Perinatol 2003, 27:393-400.
162. Tung KT, MacDonald LM, Smith JC Neonatal systemic candidiasis diagnosed by ultrasound. Acta Radiol 1990, 31:293-295.
163. Eckstein CW, Kass EJ Anuria in a newborn secondary to bilateral ureteropelvic fungus balls. J Urol 1982, 127:109-110.
164. Khan MY Anuria from Candida pyelonephritis and obstructing fungal balls. Urology 1983, 21:421-423.
165. McDonnell M, Lam AH, Isaacs D Nonsurgical management of neonatal obstructive uropathy due to Candida albicans. Clin Infect Dis 1995, 21:1349-1350.
166. Sirinelli D, Biriotti V, Schmit P, et al. Urinoma and arterial hypertension complicating neonatal renal candidiasis. Pediatr Radiol 1987, 17:156-158.
167. Faix RG, Finkel DJ, Andersen RD, et al. Genotypic analysis of a cluster of systemic Candida albicans infections in a neonatal intensive care unit. Pediatr Infect Dis J 1995, 14:1063-1068.
168. Chesney PJ, Justman RA, Bogdanowicz WM Candida meningitis in newborn infants: a review and report of combined amphotericin B-flucytosine therapy. Johns Hopkins Med J 1978, 142:155-160.
169. Goldsmith LS, Rubenstein SD, Wolfson BJ, et al. Cerebral calcifications in a neonate with candidiasis. Pediatr Infect Dis J 1990, 9:451-453.
170. Brill PW, Winchester P, Krauss AN, et al. Osteomyelitis in a neonatal intensive care unit. Radiology 1979, 131:83-87.
171. Bozynski ME, Naglie RA, Russell EJ Real-time ultrasonographic surveillance in the detection of CNS involvement in systemic Candida infection. Pediatr Radiol 1986, 16:235-237.
172. Levin S, Zaidel L, Bernstein D Intrauterine infection of fetal brain by Candida. Am J Obstet Gynecol 1978, 130:597-599.
173. Sood S, Majumdar T, Chatterjee A, et al. Disseminated candidosis in premature twins. Mycoses 1998, 41:417-419.
174. Baley JE, Annable WL, Kliegman RM Candida endophthalmitis in the premature infant. J Pediatr 1981, 98:458-461.
175. Clinch TE, Duker JS, Eagle RC, et al. Infantile endogenous Candida endophthalmitis presenting as a cataract. Surv Ophthalmol 1989, 34:107-112.
176. Stern JH, Calvano C, Simon JW Recurrent endogenous candidal endophthalmitis in a premature infant. J AAPOS 2001, 5:50-51.
177. Todd Johnston W, Cogen MS Systemic candidiasis with cataract formation in a premature infant. J AAPOS 2000, 4:386-388.
178. Shah GK, Vander J, Eagle RC Intraventricular Candida species abscess in a premature infant. Am J Ophthalmol 2000, 129:390-391.
179. Mittal M, Dhanireddy R, Higgins RD Candida sepsis and association with retinopathy of prematurity. Pediatrics 1998, 101:654-657.
180. Noyola DE, Bohra L, Paysse EA, et al. Association of candidemia and retinopathy of prematurity in very low birthweight infants. Ophthalmology 2002, 109:80-84.
181. Karlowicz MG, Giannone PJ, Pestian J, et al. Does candidemia predict threshold retinopathy of prematurity in extremely low birth weight (
182. Gago LC, Capone A, Trese MT Bilateral presumed endogenous Candida endophthalmitis and stage 3 retinopathy of prematurity. Am J Ophthalmol 2002, 134:611-613.
183. Haroon Parupia MF, Dhanireddy R Association of postnatal dexamethasone use and fungal sepsis in the development of severe retinopathy of prematurity and progression to laser therapy in extremely low-birth-weight infants. J Perinatol 2001, 21:242-247.
184. Tadesse M, Dhanireddy R, Mittal M, et al. Race, Candida sepsis, and retinopathy of prematurity. Biol Neonate 2002, 81:86-90.
185. Kremer I, Naor N, Davidson S, et al. Systemic candidiasis in babies with retinopathy of prematurity. Graefes Arch Clin Exp Ophthalmol 1992, 230:592-594.
186. Bond S, Stewart DL, Bendon RW Invasive Candida enteritis of the newborn. J Pediatr Surg 2000, 35:1496-1498.
187. Robertson NJ, Kuna J, Cox PM, et al. Spontaneous intestinal perforation and Candida peritonitis presenting as extensive necrotizing enterocolitis. Acta Paediatr 2003, 92:258-261.
188. Meyer CL, Payne NR, Roback SA Spontaneous, isolated intestinal perforations in neonates with birth weight less than 1,000g not associated with necrotizing enterocolitis. J Pediatr Surg 1991, 26:714-717.
189. Mintz AC, Applebaum H Focal gastrointestinal perforations not associated with necrotizing enterocolitis in very low birth weight neonates. J Pediatr Surg 1993, 28:857-860.
190. Kaplan M, Eidelman AI, Dollberg L, et al. Necrotizing bowel disease with Candida peritonitis following severe neonatal hypothermia. Acta Paediatr Scand 1990, 79:876-879.
191. Schelonka RL, Moser SA Time to positive culture results in neonatal Candida septicemia. J Pediatr 2003, 142:564-565.
192. Berenguer J, Buck M, Witebsky F, et al. Lysis-centrifugation blood cultures in the detection of tissue-proven invasive candidiasis. Disseminated versus single-organ infection. Diagn Microbiol Infect Dis 1993, 17:103-109.
193. Pollack CV, Pollack ES, Andrew ME Suprapubic bladder aspiration versus urethral catheterization in ill infants: success, efficiency and complication rates. Ann Emerg Med 1994, 23:225-230.
194. Faix RG Candida parapsilosis meningitis in a premature infant. Pediatr Infect Dis J 1983, 2:462-464.
195. Fernandez M, Moylett EH, Noyola DE, et al. Candidal meningitis in neonates: a 10-year review. Clin Infect Dis 2000, 31:458-463.
196. Johnson DE, Thompson TR, Green TP, et al. Systemic candidiasis in very low-birth-weight infants (less than 1,500 grams). Pediatrics 1984, 73:138-143.
197. Pfaller MA Epidemiology of nosocomial candidiasis: the importance of molecular typing. Braz J Infect Dis 2000, 4:161-167.
198. Villari P, Iacuzio L, Torre I, et al. Molecular epidemiology as an effective tool in the surveillance of infections in the neonatal intensive care unit. J Infect 1998, 37:274-281.
199. Berman LH, Stringer DA, St.Onge O, et al. An assessment of sonography in the diagnosis and management of neonatal renal candidiasis. Clin Radiol 1989, 40:577-581.
200. Krensky AM, Reddish JM, Teele RL Causes of increased renal echogenicity in pediatric patients. Pediatrics 1983, 72:840-846.
201. Erden A, Fitoz S, Karagulle T, et al. Radiological findings in the diagnosis of genitourinary candidiasis. Pediatr Radiol 2000, 30:875-877.
202. Johnson SC, Kazzi NJ Candida brain abscess: a sonographic mimicker of intracranial hemorrhage. J Ultrasound Med 1993, 12:237-239.
203. Huang CC, Chen CY, Yang HB, et al. Central nervous system candidiasis in very low-birth-weight premature neonates and infants: US characteristics and histopathologic and MR imaging correlates in five patients. Radiology 1998, 209:49-56.
204. Schelonka RL, Chai MK, Yoder BA, et al. Volume of blood required to detect common neonatal pathogens. J Pediatr 1996, 129:275-278.
205. Walsh TJ, Merz WG, Lee JW, et al. Diagnosis and therapeutic monitoring of invasive candidiasis by rapid enzymatic detection of serum d-arabinitol. Am J Med 1995, 99:164-172.
206. Flahaut M, Sanglard D, Monod M, et al. Rapid detection of Candida albicans in clinical samples by DNA amplification of common regions from C. albicans-secreted aspartic proteinase genes. J Clin Microbiol 1998, 36:395-401.
207. Mitsutake K, Miyazaki T, Tashiro T, et al. Enolase antigen, mannan antigen, Cand-Tec antigen, and beta-glucan in patients with candidemia. J Clin Microbiol 1996, 34:1918-1921.
208. Sigmundsdottir G, Christensson B, Bjorklund LJ, et al. Urine d-arabinitol/ l-arabinitol ratio in diagnosis of invasive candidiasis in newborn infants. J Clin Microbiol 2000, 38:3039-3042.
209. Van Burik JA, Myerson D, Schreckhise RW, et al. Panfungal PCR assay for detection of fungal infection in human blood specimens. J Clin Microbiol 1998, 36:1169-1175.
210. Bliss J, Wellington M, Gigliotti F Antifungal pharmacotherapy for neonatal candidiasis. Semin Perinatol 2003, 27:365-374.
211. Kicklighter SD Antifungal agents and fungal prophylaxis in the neonate. Pediatr Rev Neoreviews 2002, 2002:e249-e254.
212. Faix RG, Feick HJ, Frommelt P, et al. Successful medical treatment of Candida parapsilosis endocarditis in a premature infant. Am J Perinatol 1990, 7:272-275.
213. Munz D, Powell KR, Pai CH Treatment of candidal diaper dermatitis: a double-blind placebo-controlled comparison of topical nystatin with topical plus oral nystatin. J Pediatr 1982, 101:1022-1025.
214. Dhondt F, Ninane J, De Beule K, et al. Oral candidosis: treatment with absorbable and non-absorbable antifungal agents in children. Mycoses 1992, 35:1-8.
215. Casneuf J, de Loore F, Dhondt F, et al. Oral thrush in children treated with miconazole gel. Mykosen 1980, 23:75-78.
216. Concannon P, Gisoldi E, Phillips S, et al. Diaper dermatitis: a therapeutic dilemma. Results of a double-blind placebo controlled trial of miconazole nitrate 0.25%. Pediatr Dermatol 2001, 18:149-155.
217. Pappas PG, Rex JH, Sobel JD, et al. Guidelines for treatment of candidiasis. Clin Infect Dis 2004, 38:161-189.
218. Candidiasis. 2003 Red Book: Report of the Committee on Infectious Diseases 2003, 229-232. American Academy of Pediatrics Committee on Infectious Diseases, American Academy of Pediatrics, Elk Grove Village, Il. L.K. Pickering (Ed.).
219. Pfaller MA, Messer SA, Hollis RJ Strain delineation and antifungal susceptibilities of epidemiologically related and unrelated isolates of Candida lusitaniae. Diagn Microbiol Infect Dis 1994, 20:127-133.
220. Butler KM, Rench MA, Baker CJ Amphotericin B as a single agent in the treatment of systemic candidiasis in neonates. Pediatr Infect Dis J 1990, 9:51-56.
221. Kingo AR, Smyth JA, Waisman D Lack of evidence of amphotericin B toxicity in very low birth weight infants treated for systemic candidiasis. Pediatr Infect Dis J 1997, 16:1002-1003.
222. Baley JE, Kliegman RM, Fanaroff AA Disseminated fungal infections in very low-birth-weight infants: therapeutic toxicity. Pediatrics 1984, 73:153-157.
223. Hall JE, Cox F, Karlson K, et al. Amphotericin B dosage for disseminated candidiasis in premature infants. J Perinatol 1987, 7:194-198.
224. Serra G, Mezzano P, Bonacci W Therapeutic treatment of systemic candidiasis in newborns. J Chemother 1991, 3:240-244.
225. Glick C, Graves GR, Feldman S Neonatal fungemia and amphotericin B. South Med J 1993, 86:1368-1371.
226. Baley JE, Meyers C, Kliegman RM, et al. Pharmacokinetics, outcome of treatment, and toxic effects of amphotericin B and 5-fluorocytosine in neonates. J Pediatr 1990, 116:791-797.
227. Rowen JL, Tate JM Management of neonatal candidiasis. Neonatal Candidiasis Study Group. Pediatr Infect Dis J 1998, 17:1007-1011.
228. Baetz-Greenwalt B, Debaz B, Kumar ML Bladder fungus ball: a reversible cause of neonatal obstructive uropathy. Pediatrics 1988, 81:826-829.
229. Juster-Reicher A, Leibovitz E, Linder N, et al. Liposomal amphotericin B (AmBisome) in the treatment of neonatal candidiasis in very low birth weight infants. Infection 2000, 28:223-226.
230. Adler-Shohet F, Waskin H, Lieberman JM Amphotericin B lipid complex for neonatal invasive candidiasis. Arch Dis Child Fetal Neonatal Ed 2001, 84:F131-F133.
231. Walsh TJ, Seibel NL, Arndt C, et al. Amphotericin B lipid complex in pediatric patients with invasive fungal infections. Pediatr Infect Dis J 1999, 18:702-708.
232. Dupont B Overview of the lipid formulations of amphotericin B. J Antimicrob Chemother 2002, 49:31-36.
233. Ferrari P, Chiarolanza J, Capriotti T, et al. Favorable course of cerebral candidiasis in a low-birth weight newborn treated with liposomal amphotericin B. Pediatr Med Chir 2001, 23:197-199.
234. Al Arishi H, Frayha HH, Kalloghlian A, et al. Liposomal amphotericin B in neonates with invasive candidiasis. Am J Perinatol 1998, 15:643-648.
235. Scarcella A, Pasquariello MB, Giugliano B, et al. Liposomal amphotericin B treatment for neonatal fungal infections. Pediatr Infect Dis J 1998, 17:146-148.
236. Weitkamp JH, Poets CF, Sievers R, et al. Candida infection in very low birth-weight infants: outcome and nephrotoxicity of treatment with liposomal amphotericin B (AmBisome). Infection 1998, 26:11-15.
237. Pfaller MA, Messer SA, Boyken L, et al. In vitro activities of 5-fluorocytosine against 8,803 clinical isolates of Candida spp.: global assessment of primary resistance using National Committee for Clinical Laboratory Standards susceptibility testing methods. Antimicrob Agents Chemother 2002, 46:3518-3521.
238. Smego RA, Perfect JR, Durack DT Combined therapy with amphotericin B and 5-fluorocytosine for Candida meningitis. Rev Infect Dis 1984, 6:791-801.
239. Johnson EM, Richardson MD, Warnock DW In-vitro resistance to imidazole antifungals in Candida albicans. J Antimicrob Chemother 1984, 13:547-558.
240. Novelli V, Holzel H Safety and tolerability of fluconazole in children. Antimicrob Agents Chemother 1999, 43:1955-1960.
241. Triolo V, Gari-Toussaint M, Casagrande F, et al. Fluconazole therapy for Candida albicans urinary tract infections in infants. Pediatr Nephrol 2002, 17:550-553.
242. Saxen H, Hoppu K, Pohjavuori M Pharmacokinetics of fluconazole in very low birth weight infants during the first two weeks of life. Clin Pharmacol Ther 1993, 54:269-277.
243. Wenzl TG, Schefels J, Hornchen H, et al. Pharmacokinetics of oral fluconazole in premature infants. Eur J Pediatr 1998, 157:661-662.
244. Kicklighter SD, Springer SC, Cox T, et al. Fluconazole for prophylaxis against candidal rectal colonization in the very low birth weight infant. Pediatrics 2001, 107:293-298.
245. Driessen M, Ellis JB, Cooper PA, et al. Fluconazole vs. amphotericin B for the treatment of neonatal fungal septicemia: a prospective randomized trial. Pediatr Infect Dis J 1996, 15:1107-1112.
246. Wainer S, Cooper PA, Gouws H, et al. Prospective study of fluconazole therapy in systemic neonatal fungal infection. Pediatr Infect Dis J 1997, 16:763-767.
247. Fasano C, O'Keeffe J, Gibbs D Fluconazole treatment of neonates and infants with severe fungal infections not treatable with conventional agents. Eur J Clin Microbiol Infect Dis 1994, 13:351-354.
248. Ferrieri P, Guse D, Krumpelmann J 2002-2003 Antibiotic susceptibilities at Fairview-University Medical Center. Clinical Microbiology Laboratory Newsletter 2004, 1-2. Fairview-University Medical Center, Minneapolis, Minn.
249. Pfaller MA, Messer SA, Hollis RJ, et al. Trends in species distribution and susceptibility to fluconazole among blood stream isolates of Candida species in the United States. Diagn Microbiol Infect Dis 1999, 33:217-222.
250. Sabo JA, Abdel-Rahman SM Voriconazole: a new triazole antifungal. Ann Pharmacother 2000, 34:1032-1043.
251. Muller FM, Weig M, Peter J, et al. Azole cross-resistance to ketoconazole, fluconazole, itraconazole and voriconazole in clinical Candida albicans isolates from HIV-infected children with oropharyngeal candidosis. J Antimicrob Chemother 2000, 46:338-340.
252. Stone EA, Fung HB, Kirschenbaum HL Caspofungin: an echinocandin antifungal agent. Clin Ther 2002, 24:351-377.
253. Mora-Duarte J, Betts R, Rotstein C, et al. Comparison of caspofungin and amphotericin B for invasive candidiasis. N Engl J Med 2002, 347:2020-2029.
254. Boucher HW, Groll AH, Chiou CC, et al. Newer systemic antifungal agents: pharmacokinetics, safety and efficacy. Drugs 2004, 64:1997-2020.
255. Friedman S, Richardson SE, Jacobs SE, et al. Systemic Candida infection in extremely low birth weight infants: short term morbidity and long term neurodevelopmental outcome. Pediatr Infect Dis J 2000, 19:499-504.
256. Karlowicz MG, Hashimoto LN, Kelly RE, et al. Should central venous catheters be removed as soon as candidemia is detected in neonates?. Pediatrics 2000, 106:e63.
257. Rex JH, Walsh TJ, Sobel JD, et al. Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America. Clin Infect Dis 2000, 30:662-678.
258. Saiman L, Ludington E, Dawson JD, et al. Risk factors for Candida species colonization of neonatal intensive care unit patients. Pediatr Infect Dis J 2001, 20:1119-1124.
259. Huang YC, Lin TY, Leu HS, et al. Outbreak of Candida parapsilosis fungemia in neonatal intensive care units: clinical implications and genotyping analysis. Infection 1999, 27:97-102.
260. Burnie JP Candida and hands. J Hosp Infect 1986, 8:1-4.
261. Larson E, Silberger M, Jakob K, et al. Assessment of alternative hand hygiene regimens to improve skin health among neonatal intensive care unit nurses. Heart Lung 2000, 29:136-142.
262. Campbell JR, Zaccaria E, Baker CJ Systemic candidiasis in extremely low birth weight infants receiving topical petrolatum ointment for skin care: a case-control study. Pediatrics 2000, 105:1041-1045.